Literature DB >> 34328446

The Changing Epidemiology of Liver Disease Among US Children and Adolescents From 1999 to 2016.

Jie Li1, Michael H Le2, Monique T Barakat2,3, Ramsey C Cheung2,4, Mindie H Nguyen2,5.   

Abstract

INTRODUCTION: Nonalcoholic fatty liver disease (NAFLD) and infection with hepatitis B virus (HBV) or hepatitis C virus (HCV) are major causes of liver disease in adults. However, data for children and adolescents are limited. Our study aimed to characterize the prevalence, trend, and risk factors of infection of HBV and HCV and possible NAFLD for this population.
METHODS: We analyzed 6,647 children and adolescents (aged 6-21 years) from the 1999-2016 National Health and Nutrition Examination Survey.
RESULTS: Among individuals aged 6-21 years, HBV prevalence decreased after 2011, from 0.72% in 1999-2004 and 0.85% in 2005-2010 to 0.27% in 2011-2016 (P < 0.001), whereas HCV prevalence increased to 0.26% in 2011-2016 after an initial decline from 0.15% in 1999-2004 to 0.02% in 2005-2010 (P = 0.01). Possible NAFLD prevalence also increased by approximately 40% in individuals aged 12-21 years, from 8.54% in 1999-2004 to 10.1% in 2005-2010 and then 11.8% in 2011-2016 (P = 0.033), with most possible NAFLD individuals being male, being obese, or having higher glucose, fasting insulin, hemoglobin A1c, homeostatic model assessment of insulin resistance, liver enzymes, lipids, and uric acid (all P < 0.01). On multivariate logistic regression, hypertension (odds ratio 4.79, 95% confidence interval 1.44-15.9) and dyslipidemia (odds ratio 11.6, 95% confidence interval 5.65-23.9) increased risk for possible NAFLD but not income:poverty ratio, hours spent on computer use, or added sugars. DISCUSSION: Although HBV prevalence has decreased in recent years among US children and adolescents, HCV and possible NAFLD have increased. Public health efforts must seek further understanding of the driving factors of this increase so that age-appropriate interventions can be developed and implemented.
Copyright © 2021 by The American College of Gastroenterology.

Entities:  

Year:  2021        PMID: 34328446     DOI: 10.14309/ajg.0000000000001386

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  2 in total

Review 1.  Defer no more: advances in the treatment and prevention of chronic hepatitis C virus infection in children.

Authors:  Jonathan R Honegger; Charitha Gowda
Journal:  Curr Opin Infect Dis       Date:  2022-07-15       Impact factor: 4.968

2.  Changes in the prevalence of hepatitis B and metabolic abnormalities among young men in Korea.

Authors:  Byeong Geun Song; Dong Hyun Sinn; Wonseok Kang; Geum-Youn Gwak; Yong-Han Paik; Moon Seok Choi; Joon Hyeok Lee; Kwang Cheol Koh; Seung Woon Paik
Journal:  Korean J Intern Med       Date:  2022-05-13       Impact factor: 3.165

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.